Phosphatidylserine ホスファチジルセリン

In Japan: Foods with Function Claims notifications

Functions claimed (counted from notifications with this ingredient alone)

Examples of notified claims (our translation)

Cautions written in the notifications (most common)

• “If you are taking anticholinergic drugs, acetylcholinesterase inhibitors or cholinergic drugs, avoid taking this product.” (5 notifications)
• “If you are taking anticholinergic drugs, acetylcholinesterase inhibitors or cholinergic drugs, avoid taking this product.” (2 notifications)

Under Foods with Function Claims, the company notifies the Consumer Affairs Agency of the scientific evidence on its own responsibility; the government does not review or approve it. You can look up each product's notification by the number on the package in the Consumer Affairs Agency's database (Japanese).

In the EU: the register of health claims

Claim not authorised in the EU

• The claim on "memory and cognitive function in the elderly" for phosphatidylserine was not authorised because the ingredient was not sufficiently characterised to be assessed (2010 opinion).

In the EU, only health claims whose evidence has been assessed by the European Food Safety Authority (EFSA) and authorised by the European Commission may be used on food. “Not authorised” means the evidence for that claim was not established under EU standards — not that the ingredient is dangerous.

Other ingredients in the same categories

• GABA (gamma-aminobutyric acid)
• Lactic acid bacteria and bifidobacteria
• Lutein and zeaxanthin
• DHA and EPA
• Ginkgo leaf (flavonoid glycosides and terpene lactones)
• Astaxanthin